Prevention of drug-induced atrio-ventricular block Grant US-11806401-B2 United States of America 07 Nov 2023
Engineered liposomes as cancer-targeted therapeutics Grant US-11260132-B2 United States of America 01 Mar 2022
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents Grant US-11173119-B2 United States of America 16 Nov 2021
NON-VIRAL, NON-CATIONIC NANOPARTICLES AND USES THEREOF Application EP-3595629-A4 European Patent Office 06 Jan 2021
RNA nanoparticle for treatment of gastric cancer Grant US-10781446-B2 United States of America 22 Sep 2020
Nanoparticulate compositions comprising interferon gamma and losartan for immunotherapy Grant US-10751291-B2 United States of America 25 Aug 2020
Nanolipogel comprising a polymeric matrix and a lipid shell Grant US-10709664-B2 United States of America 14 Jul 2020
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier… Grant US-10617639-B2 United States of America 14 Apr 2020
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents Grant US-10603276-B2 United States of America 31 Mar 2020
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel Grant US-10532045-B2 United States of America 14 Jan 2020
Nanoparticle-mediated delivery of cytokines for maintenance of the regulatory T cell… Grant US-10500157-B2 United States of America 10 Dec 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause… Grant US-10449193-B2 United States of America 22 Oct 2019
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier… Grant US-10357458-B2 United States of America 23 Jul 2019
Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel Grant US-10349884-B2 United States of America 16 Jul 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that… Application US-10258691-B2 United States of America 16 Apr 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause… Grant US-10238602-B2 United States of America 26 Mar 2019
Methods of treating inflammatory and autoimmune diseases and disorders Grant US-10195144-B2 United States of America 05 Feb 2019
Combination therapy with an anti-hyaluronan agent and therapeutic agent Grant US-10137104-B2 United States of America 27 Nov 2018
Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause… Grant US-10117881-B2 United States of America 06 Nov 2018
COMBINATION THERAPY WITH HYALURONIDASE AND A TUMOR-TARGETED TAXANE Grant EP-2833905-B1 European Patent Office 02 May 2018
Combination therapy with an anti-hyaluronan agent and therapeutic agent Grant US-9913822-B2 United States of America 13 Mar 2018
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier… Grant US-9682041-B2 United States of America 20 Jun 2017
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents Grant US-9610250-B2 United States of America 04 Apr 2017
Methods of treating inflammatory and autoimmune diseases and disorders using nanolipogels Grant US-9603800-B2 United States of America 28 Mar 2017
Intravenous curcumin and derivatives for treatment of neurodegenerative and stress… Grant US-9393198-B2 United States of America 19 Jul 2016
Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT… Grant US-9138411-B2 United States of America 22 Sep 2015